Analyzing How You Should Play Cigna (CI) Ahead of Q1 Earnings [Yahoo! Finance]
IGM Biosciences, Inc. (IGMS)
Last igm biosciences, inc. earnings: 3/26 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Growth in commercial memberships and strengthening performance in Cigna Healthcare and Evernorth businesses are expected to continue driving its results. The combination of these factors, alongside other favorable conditions, is expected to have a positive impact on its stock performance, which has already been surpassing its peers in 2024. Year to date, Cigna shares have surged 19%, outpacing the industry's 4.8% decline and exceeding the S&P 500 Index's 7.6% rise. Image Source: Zacks Investment Research Another Beat in the Cards? The Zacks Consensus Estimate for the company's commercial middle market memberships suggests a 1.4% rise from the prior-year quarter's reported figure, while our estimate indicates a 1.2% jump. The consensus mark for commercial select memberships predicts a 2.5% year-over-year growth. These will help the company to boost profits. As such, the consensus mark for pre-tax adjusted income from the Cigna Healthcare unit indicates nearly 20% growth. Furt
Show less
Read more
Impact Snapshot
Event Time:
IGMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IGMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IGMS alerts
High impacting IGM Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
IGMS
News
- IGM Biosciences, Inc. (NASDAQ: IGMS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.MarketBeat
- IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewswire
- IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
IGMS
Earnings
- 5/8/24 - Beat
IGMS
Sec Filings
- 5/8/24 - Form 8-K
- 5/8/24 - Form 10-Q
- 4/26/24 - Form ARS
- IGMS's page on the SEC website